Retinal Endovascular Lysis in Ischemic Central Retinal Vein Occlusion. One-Year Results of a Pilot Study

Ophthalmology

Volumn 114, Issue 4, 2007, Pages

  Feltgen, Nicolas ^a   Junker, Bernd ^a   Agostini, Hansjuergen ^a   Hansen, Lutz L ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT;

ADULT; AGED; ARTICLE; BLINDNESS; CANNULATION; CASE STUDY; CATARACT; CENTRAL RETINA VEIN OCCLUSION; CILIARY DISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EYE EXAMINATION; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INTERVENTION STUDY; LUNG TUBERCULOSIS; LYSIS; NEOVASCULAR GLAUCOMA; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA DETACHMENT; RETINA ISCHEMIA; SURGICAL TECHNIQUE; VASCULAR ACCESS; VISION; VISUAL ACUITY; VITRECTOMY;

EID: 33947592220     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.06.064     Document Type: Article

References (32)

1. Hayreh S.S. Retinal vein occlusion. Indian J Ophthalmol 42 (1994) 109-132
2. Hayreh S.S. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 24 (2005) 493-519
3. Williamson T.H. Central retinal vein occlusion: what's the story?. Br J Ophthalmol 81 (1997) 698-704
4. Hansen L.L., Danisevskis P., Arntz H.R., et al. A randomised prospective study on treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation. Br J Ophthalmol 69 (1985) 108-116
5. Hansen L.L., Wiek J., Schade M., et al. Effect and compatibility of isovolaemic haemodilution in the treatment of ischaemic and non-ischaemic central retinal vein occlusion. Ophthalmologica 199 (1989) 90-99
6. Wolf S., Arend O., Bertram B., et al. Hemodilution therapy in central retinal vein occlusion: one-year results of a prospective randomized study. Graefes Arch Clin Exp Ophthalmol 232 (1994) 33-39
7. Hayreh S.S. Management of central retinal vein occlusion. Ophthalmologica 217 (2003) 167-188
8. Weiss J.N. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Am J Ophthalmol 126 (1998) 142-144
9. Opremcak E.M., Bruce R.A., Lomeo M.D., et al. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina 21 (2001) 408-415
10. Hattenbach L.O., Steinkamp G., Scharrer I., and Ohrloff C. Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion. Ophthalmologica 212 (1998) 394-398
11. Green W.R., Chan C.C., Hutchins G.M., and Terry J.M. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina 1 (1981) 27-55
12. Kohner E.M., Pettit J.E., Hamilton A.M., et al. Streptokinase in central retinal vein occlusion: a controlled clinical trial. Br Med J 1 (1976) 550-553
13. Elman M.J. Thrombolytic therapy for central retinal vein occlusion: results of a pilot study. Trans Am Ophthalmol Soc 94 (1996) 471-504
14. Hattenbach L.O., Wellermann G., Steinkamp G.W., et al. Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion. Ophthalmologica 213 (1999) 360-366
15. Paques M., Vallee J.N., Herbreteau D., et al. Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion. Br J Ophthalmol 84 (2000) 1387-1391
16. Lahey J.M., Fong D.S., and Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers 30 (1999) 427-434
17. Glacet-Bernard A., Kuhn D., Vine A.K., et al. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol 84 (2000) 609-613
18. Elman M.J., Raden R.Z., and Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc 108 (2001) 219-221 discussion 222-3
19. Weiss J.N., and Bynoe L.A. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 108 (2001) 2249-2257
20. Bynoe L.A., Hutchins R.K., Lazarus H.S., and Friedberg M.A. Retinal endovascular surgery for central retinal vein occlusion: initial experience of four surgeons. Retina 25 (2005) 625-632
21. Magargal L.E., Donoso L.A., and Sanborn G.E. Retinal ischemia and risk of neovascularization following central retinal vein obstruction. Ophthalmology 89 (1982) 1241-1245
22. Hayreh S.S., Klugman M.R., Beri M., et al. Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase. Graefes Arch Clin Exp Ophthalmol 228 (1990) 201-217
23. Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115 (1997) 486-491
24. Servais G.E., Thompson H.S., and Hayreh S.S. Relative afferent pupillary defect in central retinal vein occlusion. Ophthalmology 93 (1986) 301-303
25. Holladay J.T. Proper method for calculating average visual acuity. J Refract Surg 13 (1997) 388-391
26. Schulze-Bonsel K., Feltgen N., Burau H., et al. Visual acuities "hand motion" and "counting fingers" can be quantified with the Freiburger visual acuity test. Invest Ophthalmol Vis Sci 47 (2006) 1236-1240
27. Bynoe L.A., and Weiss J.N. Retinal endovascular surgery and intravitreal triamcinolone acetonide for central vein occlusion in young adults. Am J Ophthalmol 135 (2003) 382-384
28. Quinlan P.M., Elman M.J., Bhatt A.K., et al. The natural course of central retinal vein occlusion. Am J Ophthalmol 110 (1990) 118-123
29. Cotran R.S., and Pober J.S. Effects of cytokines on vascular endothelium: their role in vascular and immune injury. Kidney Int 35 (1989) 969-975
30. Hayreh M.S. t-PA in CRVO. Ophthalmology 109 (2002) 1758-1761
31. Seitz R. The retinal blood vessels. Comparative ophthalmoscopic and histological studies on the healthy and pathologically changed eye. Buch Augenarzt 40 (1962) 1-175 [in German]
32. Baseline and early natural history report: the Central Vein Occlusion Study. Arch Ophthalmol 111 (1993) 1087-1095